Qiuqing Ang

Qiuqing Ang has extensive experience in the pharmaceutical industry, with a focus on neuromedicine. Most recently, Qiuqing served as the Chief Medical Officer at SciNeuro Pharmaceuticals, where they led the development of new and effective treatments for central nervous system diseases. Prior to that, Qiuqing held positions at Klus Pharma as the Chief Scientific Officer and as the Executive Vice President, Head of Clinical Development and Clinical Science. They also worked at Pfizer as the Director of Clinical Operations Excellence and as the Director of the Primary Care Business Unit. Qiuqing's earlier experience includes roles at GSK as the Neuroscience Therapy Area Head and at Eli Lilly and Company as a Clinical Research Physician.

Qiuqing Ang has a MD degree from Shanghai Second Medical University and a PhD degree from Shanghai Medical College of Fudan University. Qiuqing Ang also completed a post-doctorate program at Indiana University School of Medicine.